About
Anna Slezak joined Abingworth's Menlo Park office in January 2026, working with the firm's transatlantic team to source and support investments. She was previously a Venture Associate at Portal Innovations, focusing on early-stage biotechnology companies across deal sourcing, due diligence, and portfolio support, and earlier interned with ARCH Venture Partners. She holds a PhD in Molecular Engineering from the University of Chicago, where her doctoral research addressed drug delivery for oncology and autoimmune disease, and a BS in Chemistry from Duke University.
Invests in
Biotech
Colleagues at Abingworth
Alex Asquith
Counsel at Abingworth
Amit Khasgiwala
Investment Professional at Innovatus Capital Partners
Andrew Sinclair
Managing Director, Head of Publics & Late Stage at Abingworth
Ankur Shah
Vice President, CCD at Abingworth
Bali Muralidhar
Global Head of Life Sciences & CIO at Abingworth
Carlos Paya
Venture Partner at Ysios Capital
Dayle Hogg
Operating Executive at Abingworth
Diya Malhotra
Principal at Abingworth
Frequently asked questions
- Who is Anna Slezak?
- Anna Slezak joined Abingworth's Menlo Park office in January 2026, working with the firm's transatlantic team to source and support investments. She was previously a Venture Associate at Portal Innovations, focusing on early-stage biotechnology companies across deal sourcing, due diligence, and portfolio support, and earlier interned with ARCH Venture Partners. She holds a PhD in Molecular Engineering from the University of Chicago, where her doctoral research addressed drug delivery for oncology and autoimmune disease, and a BS in Chemistry from Duke University.
- Where does Anna Slezak work?
- Anna Slezak is Senior Associate at Abingworth.
- What does Anna Slezak invest in?
- Anna Slezak invests in Biotech.